Epidermal growth factor (EGF)-mediated glycosylation inactivates GSK3β [29–31], while TNF-α induces COP9 signalosome 5 (CSN5)-mediated deubiquitination [32], both of which lead to stabilization of PD-L1protein in tumor cells. The gene discussed is EGF; the disease is neoplasm.